ClinicalTrials.gov
ClinicalTrials.gov Menu

Quality of Life in Lung Cancer Survivors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00586937
Recruitment Status : Active, not recruiting
First Posted : January 7, 2008
Last Update Posted : September 5, 2018
Sponsor:
Collaborator:
Fox Chase Cancer Center
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center

December 21, 2007
January 7, 2008
September 5, 2018
June 2005
June 2019   (Final data collection date for primary outcome measure)
To describe the health-related quality of life (HQOL) of lung cancer survivors and compare their HQOL with age- and gender-appropriate, population-based normative data. [ Time Frame: 2 years ]
To describe the health-related quality of life (HQOL) of lung cancer survivors and compare their HQOL with age- and gender-appropriate, population-based normative data. [ Time Frame: conclusion of study ]
Complete list of historical versions of study NCT00586937 on ClinicalTrials.gov Archive Site
To describe and identify covariates of HQOL in lung cancer survivors. [ Time Frame: 2 years ]
To describe and identify covariates of HQOL in lung cancer survivors. [ Time Frame: conclusion of study ]
Not Provided
Not Provided
 
Quality of Life in Lung Cancer Survivors
Quality of Life in Lung Cancer Survivors
The purpose of this study is to find out about the quality of life of individuals who have been diagnosed and treated for lung cancer (lung cancer survivors). By quality of life, we mean how you are feeling about different aspects of your life, including your physical health, your emotional health, and your ability to carry out daily activities. We are interested in people's opinions about their quality of life, as well as the factors that affect their quality of life. Learning about quality of life will help us to develop new services for lung cancer survivors.
Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample
Thoracic Surgery Database
Lung Cancer Survivors
Behavioral: questionnaires or telephone interview
In the first phase, a random sample of lung cancer survivors will complete a comprehensive telephone interview or questionnaire by self-report focusing on assessment of quality of life and related covariates. We estimate the total time for completion of the survey by telephone interview or self-report to be 45-60 minutes. second phase of the study, a subset of telephone survey participants will take part in a focus group discussion that will explore their perceptions of barriers for delivery of post-treatment medical and psychosocial follow-up care.
1
Lung Cancer Survivors
Intervention: Behavioral: questionnaires or telephone interview
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
193
200
June 2019
June 2019   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Diagnosis of primary Stage IA or IB NSCLC;
  • Underwent surgical resection for NSCLC at MSKCC;
  • From 1 to 5 years and 11 months post-treatment for NSCLC prior to study recruitment;
  • No evidence of disease (NED) at the time of recruitment;
  • Can be reached by telephone;
  • Able to provide informed consent.

Exclusion Criteria:

  • Undergoing active antineoplastic treatment;
  • Major psychopathology or cognitive impairment likely in the judgment of the investigator to interfere with participation and compliance with the protocol.
Sexes Eligible for Study: All
Child, Adult, Older Adult
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00586937
05-057
Not Provided
Not Provided
Not Provided
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Fox Chase Cancer Center
Principal Investigator: Jamie Ostroff, PhD Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
September 2018